Page last updated: 2024-08-23

dermatan sulfate and Thromboembolism, Venous

dermatan sulfate has been researched along with Thromboembolism, Venous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Daniel, RA; Desilva, K; Du, QS; Masci, PP; Osborne, SA; Seymour, RB; Vitetta, L; Zhao, KN1
Arepally, GM; Chong, BH; Cines, DB; Cuker, A; Greinacher, A; Gruel, Y; Linkins, LA; Morgan, RL; Mustafa, RA; Rodner, SB; Santesso, N; Selleng, S; Warkentin, TE; Wex, A1
Alings, AM; de Bree, LC; van Wijngaarden, P1
Asakura, H; Kabata, C; Kabata, T; Kitajima, I; Misaki, T; Tani, M; Tomita, K; Tsubokawa, T1
Kitaoka, K; Mouri, Y; Nakase, J; Seki, H; Tomita, K; Toribatake, Y1

Trials

1 trial(s) available for dermatan sulfate and Thromboembolism, Venous

ArticleYear
Heparin versus danaproid for prevention of venous thromboembolism after hip surgery.
    Journal of orthopaedic surgery (Hong Kong), 2009, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Fracture Fixation, Internal; Heparin; Heparitin Sulfate; Hip Fractures; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prevalence; Venous Thromboembolism

2009

Other Studies

4 other study(ies) available for dermatan sulfate and Thromboembolism, Venous

ArticleYear
Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.
    Inflammopharmacology, 2021, Volume: 29, Issue:2

    Topics: Administration, Oral; Animals; Anticoagulants; Cattle; Collagen; Dermatan Sulfate; Disease Models, Animal; Enoxaparin; Male; Rabbits; Thrombelastography; Venous Thromboembolism; Venous Thrombosis

2021
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
    Blood advances, 2018, 11-27, Volume: 2, Issue:22

    Topics: Administration, Oral; Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Recombinant Proteins; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia; Venous Thromboembolism

2018
Heparin-induced thrombocytopenia after ICD-lead flushing.
    Acta cardiologica, 2014, Volume: 69, Issue:2

    Topics: Antibodies; Anticoagulants; Cardiomyopathy, Dilated; Chondroitin Sulfates; Defibrillators, Implantable; Dermatan Sulfate; Female; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; Middle Aged; Platelet Aggregation; Platelet Factor 4; Postoperative Complications; Pulmonary Embolism; Thrombocytopenia; Treatment Outcome; Venous Thromboembolism

2014
Changes of the soluble fibrin monomer complex level during the perioperative period of hip replacement surgery.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2008, Volume: 13, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Heparin; Heparitin Sulfate; Humans; Intraoperative Period; Lupus Coagulation Inhibitor; Male; Middle Aged; Postoperative Period; Venous Thromboembolism

2008